Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Gastrointestinal Stromal Tumors × avapritinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Mastocytosis, Systemic 2 Leukemia, Mast-Cell 2 Recurrence 1 Gastrointestinal Stromal Tumors 1

Interventions

trametinib 1 ripretinib 1 dabrafenib 1 avapritinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02508532 2022-06-21

(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors

Blueprint Medicines Corporation

Phase 1 Completed

250 enrolled 36 charts 2 FDA

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡